Testing effectiveness (Phase 2)WithdrawnNCT05022394
What this trial is testing
Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study
Who this might be right for
Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage I Lung Cancer AJCC v8+10 more
M.D. Anderson Cancer Center